Doctors often cave in to patients' requests for brand-name prescription drugs even when generic versions are available, a new study suggests - a tendency that adds billions in costs for patients and the health system. Eric Campbell, HMS professor of medicine at Massachusetts General Hospital, is the report’s lead author.
News & Research
